Fin6 needle aspiration outcomes of masses detected by positron emission tomography: Correlation with standard uptake value

Acta Cytologica

Volumn 51, Issue 4, 2007, Pages 509-516

  Pansare, Vaishali ^a   Bandyopadhyay, Sudeshna ^a   Feng, Jining ^a   Bhan, Raj ^a   Joyrich, Richard ^a   Husain, Mujtaba ^a   Al Abbadi, Mousa ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Aspiration, fine needle; Positron emission tomography; Standard uptake value

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TREATMENT OUTCOME; LABORATORY DIAGNOSIS; NEEDLE BIOPSY; NEOPLASM; PATHOLOGY; PREDICTION AND FORECASTING;

NUCLEOPOLYHEDROVIRUS;

FLUORODEOXYGLUCOSE F 18;

BIOPSY, FINE-NEEDLE; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 34547132544     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325786     Document Type: Article

References (30)

1. Fritscher-Ravens A, Bohuslavizki KH, Brandt L, Bobrowski C, Lund C, Knofel WT, Pforte A: Mediastinal lymph node involvement in potentially resectable lung cancer: Comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003;123:442-451
2. Abouzied M, Crawford E, Nabi H: 18F-FDG imaging: Pitfalls and artifacts. J Nucl Med Tech 2005;33:145-155
3. Gambhir S, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME: A tabulated summary of the FDG PET literature. J Nucl Med (suppl) 2001;42:1S-93S
4. Pauwels E, Ribeiro MJ, Stoot JH: FDG accumulation and tumor biology. Nucl Med Biol 1998;25:317-322
5. Ho C: Clinical PET imaging: An Asian perspective. Ann Acad Med Singapore 2004;33:155-165
6. Dahlbom M, Hoffman EJ, Hoh CK, Schiepers C, Rosenqvist G, Hawkins RA, Phelps ME: Whole-body positron emission tomography. I. Methods and performance characteristics. J Nucl Med 1992;33:1191-1199
7. Hsu W, Hsu NY, Shen YY, Yen RF, Kao CH: Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasms using FDG-PET. Cancer Invest 2003;21:47-52
8. Yang S, Liang JA, Lin FJ, Kwan AS, Kao CH, Shen YY: Differentiating benign and malignant pulmonary lesions with FDG-PET. Anticancer Res 2001;21:4153-4157
9. Hagge R., Wong TZ, Coleman RE: Positron emission tomography: Brain tumors and lung cancer. Radiol Clin North Am 2001;39:871-881
10. Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M, Joensuu H: Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer. J Nucl Med 1997;38:1907-1911
11. Holder WJ, White RL Jr, Zuger JH, Easton EJ Jr, Greene FL: Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998;227:764-769
12. Hubner K, Buonocore E, Singh SK, Gould HR, Cotten DW: Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med 1995;20:293-298
13. Dewan NC, Redepenning LS, Phalen JJ, Frick MP: Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104:997-1002
14. Knight S, Delbeke D, Stewart JR, Sandler MP: Evaluation of pulmonary lesions with FDG-PET. Chest 1996;109:982-988
15. Mitchell J, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S: Preoperative evaluation of thyroid nodules with 18 FDG-PET/CT. Surgery 2005;138:1166-1174
16. Shim S, Lee KS, Kim BT, Chung MJ, Lee EH, Han J, Choi JY, Kwon OJ, Shim YM, Kim S: Non-small cell lung cancer: A prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1011-1019
17. Higashi K, Clavo AC, Wahl RL: Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:419-421
18. Brown R, Leung JY, Fisher S, Frey KA, Ethier SP, Wahl RL: Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between glut-1 expression and FDG uptake. J Nucl Med 1996;37:1042-1047
19. Collins B, Gardner LJ, Verma AK, Lowe VJ, Dunphy FR, Boyd JH: Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia. Acta Cytol 1998;42:1325-1329
20. Collins B, Lowe VJ, Dunphy FR: Initial evaluation of pulmonary abnormalities: CT-guided fine needle aspiration and fluoride-18 fluorodeoxyglucose positron emission tomography correlation. Diagn Cytopathol 2000;22:92-96
21. Collins B, Lowe VJ, Dunphy FR: Correlation of CT-guided fine needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagn Cytopathol 1999;21:39-42
22. Vansteenkiste J, Stroonbants SG, De Leyn PR, DuPont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA: Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer. Chest 1997;112:1480-1486
23. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Visual and semiquantitative analyses for F18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thoracic Surg 2005;79:984-988
24. Kapucu L, Meltzer CC, Townsend DW, Keenan RJ, Luketich JD: Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med 1998;39:1267-1269
25. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, Taniguchi M, Tonami H, Okimura T, Yamamoto I: Fluorine-18-FDG PET imaging is negative in bronchoalveolar carcinoma. J Nucl Med 1998;39:1016-1020
26. Ioannidis J, Lau J: 18F-FDG PET for diagnosing and grading of soft tissue sarcoma: A meta-analysis. J Nucl Med 2003;44:717-724
27. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK: Accuracy of positron emmision tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA 2001;21:914-924
28. Savage C, Zwischenberger JB: Image-guided fine needle aspirate strategies for staging of lung cancer. Clin Lung Cancer 2000;2:101-110
29. Port J, Andrade RS, Levin MA, Korst RJ, Lee PC, Becker DE, Altorki NK: Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 2005;130:1611-1615
30. Isasi C, Lu P, Blaufox MD: A metaanalysis of 18F-2-deoxy-2-fluoro-D- glucose positron emission tomography in staging and restaging of patients with lymphoma. Cancer 2005;104:1066-1074